Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 3,049Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1SANOFI-AVENTIS CANADA INC

02 1APOTEX INC

03 1MYLAN PHARMACEUTICALS ULC

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
2024 ACI Convention
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Regulatory Info : Prescription

Registration Country : Canada

RILUZOLE

Brand Name : RILUTEK

Dosage Form : TABLET

Dosage Strength : 50MG

Packaging : 60

Approval Date :

Application Number : 2242763

Regulatory Info : Prescription

Registration Country : Canada

Sanofi Company Banner

02

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

RILUZOLE

Brand Name : APO-RILUZOLE

Dosage Form : TABLET

Dosage Strength : 50MG

Packaging : 60

Approval Date :

Application Number : 2352583

Regulatory Info : Prescription

Registration Country : Canada

blank

03

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

RILUZOLE

Brand Name : MYLAN-RILUZOLE

Dosage Form : TABLET

Dosage Strength : 50MG

Packaging : 60

Approval Date :

Application Number : 2390299

Regulatory Info : Prescription

Registration Country : Canada

blank